BioLargo Cash Flow - Annual (OTCMKTS:BLGO)

Add to My Stocks
$0.28 $0.01 (3.45%) BLGO stock closing price Aug 14, 2018 (Closing)

The financial analysis of BLGO requires an investor to check the cash flows for BioLargo. Financials statements like the BioLargo income statement and BioLargo balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. BioLargo saw a cash impact of $1.37M from the issuance of BLGO shares. The cash flow statement helps in the BioLargo stock analysis by providing more information for evaluating changes in assets, liabilities and equities. BioLargo saw a outflow of $-0.02M from investing activities for 2017.

View details of BioLargo cash flows for latest & last 10 financial years
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011201020092008
Net Income Cash Flow
-9.54M-8.07M-5.07M-3.73M-2.9M-5.33M-3.95M-5.74M-15.61M-7.14M
Depreciation Depletion Amortization Cash-Flow--------1.11M1.1M
Net Increase (Decrease) in Assets Liabilities-0.03M-0.18M-0.12M-------
Cash From (used in) Discontinued Operations----------
Other Adjustments Net5.27M4.52M3.31M1.81M1.63M3.23M1.79M3.64M12.37M3.75M
Net Cash from (used by) Operating Activities
-4.28M-3.72M-1.88M-1.71M-1.21M-2.03M-1.71M-1.29M-1.36M-1.89M
Increase (Decrease) in Prop Plant And Equipment-0.02M-0.06M--------0.02M
Acquisition Disposition of Subsidiaires----------
Increase (Decrease) in Investments----------
Other Cash Inflow (Outflow) from Investment Activities----------
Net Cash from (used by) Investment Activities
-0.02M-0.06M--------0.02M
Issuance (Purchase) of Equity Shares1.37M-3.55M1.58M-2.05M1.44M1.06M--
Issuance (Repayment) of Debt Securities----------
Increase (Decrease) in Bank & Other Borrowings1.99M3.1M-----0.02M-1.34M-
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities---0.02M-------
Net Cash from (used by) Financing Activities
3.37M3.97M3.53M1.78M1.15M2.05M1.42M1.58M1.41M1.56M
Effect of Exchange Rate Changes on Cash--0.04M-0.04M-------
Net Change in Cash & Cash Equivalents
-0.91M-1.6M--0.05M--0.29M---0.36M
Cash & Equivalents at Beginning of Year1.91M1.76M--------
Cash & Equivalents at Year End-1.91M1.76M-------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The BioLargo stock price history and BioLargo stock comparison chart inevitably reflect its cash flow situation.

  • BioLargo saw a positive change in Net Change in Cash and Cash Equivalents of $-0.91M in 2017. Apart from the BioLargo stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • The cash generated from the core business or operations was a negative at $-4.28M for BioLargo in the latest 2017. For an internet company, this would include all those activities which are involved in eventually selling advertisement space on its website or any online service.
  • Cash from investing stood at a negative value of $-0.02M for BLGO stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Cash Flow from financing activities: Financing activities include the cash that comes into a company in the form of loans or interest earned or shareholders money, as well as the cash that goes out. BioLargo earned $3.37M from financing activities, in the form of repayment of loans or interest paid, dividend pay-out to shareholders etc.

Key Financial Ratios For BioLargo Cash Flow